You are here

Research Projects

Leukaemia stem cells are thought to be the source of relapse following treatment with conventional therapies. New and emerging treatments are better...
Supervisor: Dr Omer Gilan

We are developing a platform for TCR and antibody-antigen discovery and engineering by conventional serology and T-cell assays, multiplex antigen...

The glymphatic system is the brain's method for clearing waste products to allow for appropriate functioning. In certain diseases, this system...

Viral hepatitis is responsible for more deaths globally than HIV and malaria, with hepatitis C virus (HCV) accounting for a third of viral hepatitis...

Urinary tract infections are highly prevalent, afflicting over 400 million people globally each year. The most common cause is uropathogenic E. coli...
Supervisor: Dr Malcolm Starkey

**New Projects On Offer for 2025** Metabolic memory is the name given to the phenomenon whereby previous exposure to metabolic perturbations has...
Supervisor: Professor Sam El-Osta

Bronchopulmonary dysplasia (BPD) is a severe lung disease that is the main cause of disability and death in premature infants. We have discovered...

Epilepsy is complex brain disorder, and many patients are not adequately treated with existing therapies. New therapeutic avenues are needed, such as...

The Optimise Study is a multiplatform study exploring the impact of COVID-19 on the community; this includes assessing the communities understanding...

Post-traumatic epilepsy (PTE) accounts for 20% of symptomatic epilepsy. Despite multiple studies have identified male sex as one of the risk factors...
Supervisor: Dr. Runxuan Lin

Brain inflammation appears to play a critical role in the pathogenesis of epilepsy. A major cell type involved in inflammatory cascades are the...

Oesophageal function is complex and various methods have been developed to assess this. Oesophageal manometry, which involves synchronous recording...
Supervisor: Dr Paul Burton

The development of diabetic complications including vascular and renal disease is enhanced in diabetic patients. However, the underlying mechanism as...
Supervisor: Dr Jay C. Jha

This project seeks to further improve the behavior of our prototype peptide inhibitor CHA-061 against the profibrotic effect of CDA1. CHA-061 is a...
Supervisor: Dr Zhong-Lin Chai

Epilepsy is one of the most common serious chronic neurological disorders and is estimated to affect approximately 68 million people worldwide....

Bronchopulmonary dysplasia (BPD) is a severe lung disease that is the main cause of disability and death in premature infants. Recent studies suggest...

Inborn Errors of Immunity (IEIs) are caused by rare genetic variants. Despite of major advances in genetics, in many patients no rare causative...
Supervisor: Dr Emily Edwards

Cancer is a heterogeneous disease, with differences not only among different patients, but even amongst the bulk of cells within tumors in individual...
Supervisor: Dr Mark Shackleton

Based at the Central Clinical School, our laboratory works closely with clinicians at the Alfred Hospital to study mechanisms of cancer development...
Supervisor: Dr Gamze Kuser Abali

Pages